Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection
- 13 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 45 (8), 831-837
- https://doi.org/10.1007/s00535-010-0222-8
Abstract
Endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) generally takes longer to perform than conventional endoscopy and usually requires moderate/deep sedation with close surveillance for patient safety. The aim of this study was to compare the safety profiles and recovery scores propofol continuous infusion and intermittent midazolam (MDZ) injection as sedation for ESD. Sixty EGC patients scheduled for ESDs between August and November 2008 were included in this prospective study and randomly divided into a propofol (P-group, 28 patients) and an MDZ (M-group, 32 patients) group using an odd–even system. The P-group received a 0.8 mg/kg induction dose and a 3 mg/kg/h maintenance dose of 1% propofol using an infusion pump. All patients received 15 mg pentazocine at the start of the ESD and at 60-min intervals thereafter. We recorded and analyzed blood pressure, oxygen saturation and heart rate during and following the procedure and evaluated post-anesthetic recovery scores (PARS) and subsequent alertness scores. The propofol maintenance and total dose amounts were (mean ± standard deviation) 3.7 ± 0.6 mg/kg/h and 395 ± 202 mg, respectively. The mean total dose of MDZ was 10.3 ± 4.5 mg. There were no cases of de-saturation p < 0.05). The mean PARS 15 and 30 min after the ESDs were significantly higher in the P-group (9.6/9.9) than in the M-group (8.6/9.2; p < 0.01). Based on our results, the ESDs for EGC performed under sedation using propofol continuous infusion were as safe as those performed using intermittent MDZ injection. Propofol-treated patients had a quicker recovery profile than those treated with MDZ. We therefore recommend the use of continuous propofol sedation for ESD, but sedation guidelines for the use of propofol are necessary.Keywords
This publication has 37 references indexed in Scilit:
- Propofol Sedation during Endoscopic Procedures: Safe and Effective Administration by Registered Nurses Supervised by EndoscopistsEndoscopy, 2006
- Training guideline for use of propofol in gastrointestinal endoscopyGastrointestinal Endoscopy, 2004
- Non-anesthetist Administered Propofol for ERCP; Efficacy, Safety Profile and Side Effect: A Prospective Randomized TrialGastrointestinal Endoscopy, 2004
- Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: A randomized, controlled trialGastrointestinal Endoscopy, 2002
- Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: A randomized, controlled trialGastrointestinal Endoscopy, 2002
- Guidelines for the use of deep sedation and anesthesia for GI endoscopyGastrointestinal Endoscopy, 2002
- Propofol Versus Midazolam for Conscious Sedation Guided by Processed EEG During Endoscopic Retrograde Cholangiopancreatography: A Prospective, Randomized, Double-Blind StudyEndoscopy, 2000
- Improved Sedation in Diagnostic and Therapeutic ERCP: Propofol is an Alternative to MidazolamEndoscopy, 2000
- Cardiovascular responses, arterial oxygen saturation and plasma catecholamine concentration during upper gastrointestinal endoscopy using conscious sedation with midazolam or propofolEuropean Journal of Anaesthesiology, 1998
- Sedation for Upper Gastrointestinal Endoscopy: a Comparative Study of Propofol and MidazolamEndoscopy, 1995